St Thomas' Hospital

Running trials

• Recruiting

  A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.

  NCT07357675· Phase 3· Source

• Recruiting

  A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

  NCT07830732· Phase 3· Source

• Recruiting

  A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A

  NCT07416526· Phase 3· Source

• Recruiting

  A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

  NCT07416604· Phase 3· Source

• Recruiting

  Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies

  NCT07228962· Source

• Recruiting

  A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma

  NCT07009236· Source

• Recruiting

  Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

  NCT07080905· Phase 3· Source

• Enrolling by invitation

  A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice

  NCT07055607· Source

• Recruiting

  A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma

  NCT06669247· Phase 1/2· Source

• Recruiting

  Cryoballoon/Radiofrequency/Pulsed Field Ablation of Atrial Fibrillation Versus Medical Treatment for Heart

  NCT06505798· Source

• Recruiting

  A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

  NCT06379789· Phase 1/2· Source

• Recruiting

  Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

  NCT05976685· Source

• Active, not recruiting

  Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE)

  NCT06181240· Source

• Active, not recruiting

  A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy

  NCT05568459· Source

• Recruiting

  BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  NCT06059638· Source

• Active, not recruiting

  Avacostar - (PASS)

  NCT05897684· Source

• Active, not recruiting

  Predicting the Risk of Non-culprit Coronary Artery Disease After a Heart Attack

  NCT05781087· Source

• Active, not recruiting

  A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A

  NCT05685238· Phase 3· Source

• Enrolling by invitation

  A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)

  NCT05768386· Phase 4· Source

• Active, not recruiting

  The Euro-CRAFT Registry

  NCT05805462· Source

• Recruiting

  The "Global Paradise System" Registry

  NCT05027685· Source

• Recruiting

  Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

  NCT05102019· Source

• Recruiting

  Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

  NCT04774159· Phase 3· Source

• Recruiting

  The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study

  NCT04204915· Source

• Active, not recruiting

  AMPLATZER PFO Occluder Post Approval Study

  NCT03309332· Source

• Active, not recruiting

  Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

  NCT02922036· Source

• Recruiting

  Biology of Juvenile Myoclonic Epilepsy

  NCT03400371· Source

• Active, not recruiting

  REDUCER-I: An Observational Study of the Neovasc Reducer™ System

  NCT02710435· Source

• Active, not recruiting

  HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

  NCT01915615· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Haemophilia6 recruiting
• Coronary artery disease3 recruiting
• Atrial fibrillation2 recruiting
• Stroke2 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Epilepsy1 recruiting
• Glaucoma1 recruiting
• Heart failure1 recruiting
• High blood pressure1 recruiting
• Multiple myeloma1 recruiting
• Obesity1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05633355· Phase 3· Source

• Completed

  A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05595642· Phase 3· Source

• Completed

  Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure

  NCT05419115· Phase 2· Source

• Completed

  A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors

  NCT05306418· Phase 3· Source

• Completed

  A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors

  NCT05053139· Phase 3· Source

• Completed

  A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT03524092· Phase 3· Source

• Completed

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· Phase 3· Source

• Completed

  Confirm Rx Insertable Cardiac Monitor SMART Registry

  NCT03505801· Source

• Completed

  Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301)

  NCT03370913· Phase 3· Source

• Completed

  Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke

  NCT02898610· Phase 3· Source

• Completed

  Gene Therapy Study in Severe Haemophilia A Patients (270-201)

  NCT02576795· Phase 1/2· Source

• Completed

  A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease

  NCT02100722· Source

• Completed

  Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.

  NCT01467427· Phase 3· Source

• Recruiting

  Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

  NCT00825929· Phase 4· Source

Trial sites

• St Thomas' Hospital2 trials
• King's College London (St. Thomas' Hospital)1 trial
• St Thomas Hospital33 trials
• St Thomas' Hospital, Centre for Hemophilia, Hemostasis and Thrombosis1 trial
• St Thomas' Hospital - Diabetes1 trial
• St Thomas' Hospital - Haemostasis and Thrombosis Centre5 trials
• St. Thomas Hospital, King's College1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Sickle cell disease10 works · 0 trials
• Myeloproliferative neoplasms6 works · 0 trials
• Retinitis pigmentosa4 works · 0 trials